Physician profile
Saritha Dodla
NPI 1932294469
$2,352.56
in general payments reported to CMS, 2019-2025
24 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $142 · 2021: $285 · 2022: $445 · 2023: $459 · 2024: $514 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $630.65 | 2019-2025 | Jot Dx, Agilis Hispro, Ensite Precision |
| Merck Sharp & Dohme LLC | $283.97 | 2021-2023 | Verquvo |
| Pfizer INC. | $194.98 | 2019-2024 | |
| Cleerly, INC. | $194.69 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Astrazeneca Pharmaceuticals LP | $154.86 | 2021-2022 | |
| Boston Scientific Corporation | $109.85 | 2023-2025 | Bodyguardian, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $86.28 | 2021-2025 | Eliquis |
| Kiniksa Pharmaceuticals, LTD. | $82.65 | 2022-2023 | Arcalyst |
| Inspire Medical Systems, INC. | $82.17 | 2023-2024 | Inspire |
| Tactile Systems Technology INC | $65.42 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Novartis Pharmaceuticals Corporation | $61.22 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $60.64 | 2021-2024 | |
| Medtronic, INC. | $43.89 | 2022-2024 | Ffrangio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.33 | 2021-2023 | Jardiance |
| Scpharmaceuticals INC. | $41.48 | 2023-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $41.01 | 2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $37.05 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.46 | 2020-2025 | Lifevest |
| Philips North America LLC | $26.22 | 2024 | (Ck4) Mcot |
| Kiniksa Pharmaceuticals International, Plc | $23.60 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $22.11 | 2025 | Assure Wcd |
| Glaxosmithkline, LLC. | $14.95 | 2025 | Shingrix, Arexvy |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2021 | |
| Cardinal Health 200 LLC | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saritha Dodla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.